Apart from this, STAT3 inhibition can regulate the production of various immunomodulator factors in TME of breast cancer, such as upregulation of INFs, GM-CSF and IL-2, downregulation of TGF-b, IL-6, and IL-10 proteins [163]. Here, STAT3 is linked to breast carcinoma.